300 participants
Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2024-06-13
- Start Date:
- 2022-01-20
- Completion:
- 2023-12-31
Conditions
- Hepatocellular Carcinoma Non-resectable
Interventions
- PROCEDURE
- DRUG
No Results Yet